Avantor (NYSE:AVTR) Issues Earnings Results

Avantor (NYSE:AVTR) announced its quarterly earnings results on Wednesday. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02, FiscalAI reports. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.61 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The company’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.24 earnings per share. Avantor updated its FY 2026 guidance to 0.800-0.830 EPS.

Here are the key takeaways from Avantor’s conference call:

• Q2 results exceeded expectations, with revenue of $1.69 billion, adjusted EPS of $0.21, and $152 million in free cash flow excluding restructuring costs.
• VWR Distribution & Services returned to organic growth, up 1.7% year over year, supported by stronger large-customer execution, improved e-commerce performance, and increased pharma and biotech activity.
• Avantor raised its 2026 organic revenue growth outlook to -0.5% to 0.5% and adjusted EPS guidance to $0.80-$0.83, while expecting BMP to return to growth in the second half.
• Strong cash generation enabled $112 million of debt repayment during the quarter and nearly $500 million over the past 12 months; management remains committed to reducing adjusted net leverage below 3 times by year-end.
• BMP organic revenue declined 5.6% in Q2, while consolidated and segment margins faced lower volumes, inflation, freight costs, and unfavorable product mix; education and European demand also remained weaker than desired.

Avantor Trading Up 13.2%

AVTR traded up $1.63 during trading on Wednesday, hitting $14.05. 23,481,127 shares of the company’s stock were exchanged, compared to its average volume of 10,684,112. The company has a current ratio of 1.76, a quick ratio of 1.17 and a debt-to-equity ratio of 0.68. Avantor has a 1 year low of $7.26 and a 1 year high of $15.93. The stock has a 50 day moving average price of $9.89 and a 200 day moving average price of $9.39. The firm has a market cap of $9.60 billion, a P/E ratio of -17.43, a price-to-earnings-growth ratio of 6.55 and a beta of 0.94.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on AVTR shares. Zacks Research upgraded Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, April 30th. Barclays upped their price objective on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, June 24th. TD Cowen restated a “hold” rating on shares of Avantor in a research report on Wednesday, July 15th. Sanford C. Bernstein assumed coverage on shares of Avantor in a research note on Friday, June 26th. They issued a “market perform” rating and a $10.50 target price for the company. Finally, Citigroup boosted their price target on Avantor from $9.00 to $11.00 and gave the company a “neutral” rating in a report on Wednesday, July 8th. Two research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Avantor currently has an average rating of “Reduce” and an average price target of $10.62.

Insider Buying and Selling at Avantor

In related news, Director Simon Dingemans purchased 25,000 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the acquisition, the director owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gregory T. Lucier acquired 10,000 shares of Avantor stock in a transaction on Friday, May 8th. The shares were bought at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the purchase, the director owned 60,000 shares of the company’s stock, valued at $499,200. This represents a 20.00% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On Avantor

Large investors have recently modified their holdings of the stock. AXA S.A. acquired a new stake in Avantor in the second quarter valued at approximately $255,000. Fieldview Capital Management LLC purchased a new stake in shares of Avantor during the fourth quarter valued at approximately $213,000. Prelude Capital Management LLC acquired a new position in shares of Avantor during the third quarter worth $212,000. Smartleaf Asset Management LLC lifted its position in shares of Avantor by 9,045.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 11,066 shares of the company’s stock worth $127,000 after purchasing an additional 10,945 shares in the last quarter. Finally, American Trust purchased a new position in shares of Avantor in the fourth quarter valued at $125,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.